Nebius director's trust proposes sale of 50 shares
Three earlier sales by the trust are also reported as 10b5-1 transactions dated July 15, August 14 and September 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nebius Group N.V. is named as issuer in a Form 144 notice for a proposed sale of 50 common shares for the account of the John W. Boynton IV Trust of 2006; John W. Boynton IV is identified as a director. The shares have an aggregate market value of $11,866.50, with an approximate sale date of September 29, 2026. Morgan Stanley Smith Barney LLC is listed as broker and NASDAQ as the exchange. The notice lists 238,400,165 shares outstanding and three prior 10b5-1 sales by the trust.
Key Figures
Key Terms
10b5-1 Sales regulatory
Restricted Stock Units financial
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior NBIS sales does the notice report for the trust?
AI-generated analysis. How Rhea-AI works. Not financial advice.